Discovery of a novel tetrahydroacridine acetylcholinesterase inhibitor through an indexed combinatorial library  by Pirrung, Michael C. et al.
Discovery of a novel tetrahydroacridine 
acetylcholinesterase inhibitor through 
an indexed combinatorial library 
Michael C Pirrung*, Joseph H-L Chau and Jrlung Chen 
Department of Chemistry, Duke University, PM Gross Chemical Laboratory, Durham, NC 27708-0346, USA 
Background: Methods for the rapid and efficient 
preparation of drug candidates through combinatorial 
chemistry are of increasing interest. We have previously 
reported an indexed combinatorial library method that 
allows both the preparation and testing of compounds in 
solution. We set out to apply this method to develop 
more effective analogs of the known, marketed drug 
tacrine, an acetylcholinesterase inhibitor. 
Results: A one-step condensation of cyclohexanones with 
cyanoanilines to generate tetrahydroacridine pools was 
developed. The resulting library of (formally) 72 tetra- 
hydroacridines was screened against acetylcholinesterase, 
and a compound lo-fold more potent than tacrine, 7- 
nitrotacrine, was discovered. Its increased potency could be 
readily explained by examining the known structure of the 
complex of acetylcholinesterase with tetrahydroacridine. 
Conclusions: In this work, we have provided a relatively 
rare example of carbon-carbon bond formation in a pool 
synthesis, and have discovered a potentially useful acetyl- 
cholinesterase inhibitor. 
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Introduction 
Methods for the efficient preparation of libraries of drug 
candildates in a format that can be readily screened are of 
increasing importance [1,2]. Much previous work in 
combinatorial chemistry has focused on oligomeric com- 
pounds, but methods for the preparation of non- 
oligomeric chemical diversity will clearly be crucial to 
the widest application of combinatorial principles to drug 
discovery [3,4]. We recently described the principle of 
indexed combinatorial libraries [5], which permits any 
straightforward chemical linking chemistry to be used, 
provides compounds in a soluble format ready for screen- 
ing, and does not require the iterative synthesis used in 
other deconvolution methods. We applied the indexing 
methlod to the discovery of carbamate inhibitors of 
acetylcholinesterase [6]. Another group has used essen- 
tially the same method to discover an inhibitor of matrix 
metalloproteinase-1 and a ligand for the neurokinin NK3 
receptor [7]. A similar concept called ‘orthogonal’ chemi- 
cal libraries has recently been used to discover a novel 
tripeptide ligand for the vasopressinV2 receptor [8]. 
The mdexing method relies on the following principle, 
exemplified for the simplest case of two different molec- 
ular subunits that are united to form a drug candidate. 
Variants of each subunit (in the example shown, A-H 
and 1-6) are used to generate molecular diversity. The 
complete library of all possible combinations is never 
actually synthesized in an indexed combinatorial library 
experiment; instead, many sub-libraries or pools are pre- 
pared. The pools can be considered to form a two- 
dimensional matrix in which the first subunit varies 
along one axis and the second varies along the other axis 
(Fig. l), although of course the concept is not limited to 
two dimensions. The synthesis of the pools of com- 
pounds is organized in such a way that two pools on dif- 
ferent axes always have a single component in common. 
Pools on the same axis have no components in common. 
Pools with these characteristics are obtained by reacting a 
single representative of one subunit class with all 
members of the other subunit class. When these pools are 
tested for a biological activity, the identification of the 
two most potent pools thereby identifies the single com- 
pound they have in common as the most potent in the 
I- - Al A6 Bl 86 Cl-C6 Dl-D6 El-E6 Fl-F6 Cl-G6 Hl-H6 
Fig. 1. An indexed combinatorial library can be viewed as a two- 
dimensional matrix. The identification of the two most potent 
pools (in this case pool 4, containing members 4A-4H and pool F, 
containing members Fl-F6) immediately identifies the most potent 
compound in the library as the compound that these two pools 
have in common, which in the example shown is compound 4F. 
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library, provided that there is no synergism or antagon- 
ism between pool members. In the example shown, of 
the six pools that are formed from 1-6, pool 4 is the 
most potent. Of the twelve pools formed from A-H, 
pool F is most potent.The only component they have in 
common is combination 4F, which must therefore be 
the most potent in the library This method offers the 
advantage that the sub-libraries are prepared simultan- 
eously and tested simultaneously, and the assay results 
directly point to the compound of most interest. No 
iteration is required, unlike the situation with ‘deconvo- 
lution’ methods, where active pools are first found, and 
the individual components within active pools must 
then be resynthesized for further testing. 
We have directed our further efforts to develop the 
indexed combinatorial library method toward novel 
heterocyclic inhibitors of acetylcholinesterase. Such com- 
Fig. 2. One-step C-C bond-forming 
reaction to generate tetrahydroacridines. 
The presumed mechanism of reaction is 
also shown (below). 
gravis and glaucoma [9-111. We have focused on tacrine 
(tetrahydroacridine), a cognition-enhancing drug used in 
Alzheimer’s disease, whose molecular basis of action is 
thought to rely on inhibition of acetylcholinesterase [12]. 
Symptomatic treatment of conditions such as Alzheimer’s 
disease, which are characterized by an acetylcholine 
deficit at cholinergic synapses, can be achieved by con- 
trolled inhibition of acetylcholinesterase. The indexed 
library method is particularly applicable to tetra- 
hydroacridines because it uses solution chemistry and 
provides soluble compounds for testing. The solid-phase 
synthesis of a library of tetrahydroacridines would be dif- 
ficult because they do not have a site available for attach- 
ment to a support. Furthermore, testing the drug 
candidates in solution permits one to assay the desired 
effect, enzyme inhibition, directly. When the library is 
tested while immobilized on a solid support, a surrogate 
endpoint, such as binding to the biological target, must be 
pounds are used in the treatment of inter uliu, myasthenia used instead. 
(a) 
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Fig. 3. Building blocks for the tetrahydroacridine combinatorial library. (a) Cyclohexanone building blocks (compounds A-l); 
(b) o-cyanoaniline building blocks (compounds l-6). 
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Fig. 4. Combinatorial reactions for the 
preparation of pools. (a) Preparation of 
pools in which a cyclohexanone is the 
unitary reagent (example shown for 
compound A). (b) Preparation of pools 
in which an o-cyanoaniline is the 
unitary reagent (example shown for 
compound 2). A l-6 
(b) 
2 
A one-step condensation of cyclohexanones with 
cyanoanilines to generate tetrahydroacridine pools was 
developed in our laboratory based on earlier reactions of 
cyanoanilines with ketones [13], and the resulting library 
of (formally) 72 tetrahydroacridines was screened against 
acetylcholinesterase. A novel inhibitor was discovered 
whose increased potency could be readily explained 
through analysis of the structure of the known 
acetylcholinesterase-tetrahydroacridine complex. This 
combinatorial library is a rare example in which 
carbon-carbon bond formation has been accomplished. 
Results 
A library of tetrahydroacridines consisting of 18 sub- 
pools was prepared based on the indexing principle. An 
acid--catalyzed, one-step, C-C bond-forming reaction of 
aminobenzonitriles and cyclohexanones to form the 
basic tetrahydroacridine structure (Fig. 2) was developed. 
The utility of a variety of aminobenzonitriles (all com- 
mercially available) was investigated for this reaction. The 
3,5-dinitro and 3-chloro-5-nitro substitutions were 
shown to have very low reactivity, and were conse- 
quently omitted from the library synthesis. The reaction 
was applied to basis sets of the 12 cyclohexanones in 
Figure 3a (symmetrical so as to avoid the possible pro- 
duction of positional isomers) and 6 o-cyanoaniline 
derivatives in Figure 3b. The 18 ‘row’ and ‘column’ reac- 
tions each use one fixed reagent from one of the two 
classes of reactants (the unitary reagent) and a mixed 
reagent containing all of the members of the other basis 
set (Fig. 4). Each of the basis set molecules is the unitary 
reagent in only one reaction of the 18; in the mixed 
reagent, all the members of the appropriate basis set are 
equimolar. Reactions were run to completion and the 
‘yields’ of the pools were nearly quantitative. A selection 
of the individual components in these pools was pre- 
pared and the presence of the expected members in each 
row and column reaction was verified by high-pressure 
liquid chromatography (HPLC). The resulting 18 pools 
were used to determine aggregate IC,, values against 
Fig. 5. Inhibition of acetylcholinesterase 
by tetrahydroacridines displayed as 
l/K,, (IO6 M-t), so that higher bars 
represent more potent inhibition. 
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Fig. 6. Structure of the most potent compound in this library, 
nitrotetrahydroacridine (2C), and that of tacrine. 
acetylcholinesterase (Fig. 5). Select compounds in the 
active rows and columns were individually synthesized 
and assayed.The most potent inhibitor in this library is 
1,2,3,4-tetrahydro-7-nitro-9-aminoacridine (%C, Fig. 6), 
a heretofore unknown compound [l].The statistical cri- 
terion we have developed for pool screening (the hit is 
significant if Rhit - R, > 42&n, where R is the 
response function, t is Student’s t, (T is standard deviation 
and n is the number of compounds in the pool [5]) 
could be applied to the assay values and standard devia- 
tions (Table 1) for the active column to demonstrate that 
the superior activity of 2C is significant at the 99.9% 
confidence level. When tested in pure form, 2C shows 
lo-fold greater potency (Ki = 10 nM, Fig. 7) than the 
parent compound, tacrine. To validate the discovery of 
this compound and test the ability of the method to find 
potent compounds present in small amounts in multi- 
component mixtures, novel versions of column C were 
prepared using log serial dilutions of only cyanoaniline 2, 
with all other cyanoanilines maintained at their usual 
level.This experiment formally tests pool sizes equivalent 
to 60 and 600 compounds without actually changing the 
constituents. The l/IC,, values are 38 (in units of 
Table 1. Acetylcholinesterase inhibition by rows (A-l), 
columns (l-6) and by individual members of the library. 
l/K,, S.D. l/IC,, S.D. 
A 10.4 0.6 1 8.2 0.4 
B 6.4 0.3 2 36.4 3.0 
C 18.1 0.9 3 8.2 0.5 
D 8.0 0.8 4 4.3 0.3 
E 10.3 0.5 5 15.8 0.9 
F 5.7 0.1 6 3.2 0.3 
G 7.3 0.3 1c 7.9 0.3 
H 12.9 1.0 2c 31.1 1.6 
I 2.1 0.2 5c 8.3 0.4 
I 4.3 0.3 2E 1.57 0.05 
K 1.1 0.1 2F 3.0 0.1 
1 7.2 0.3 2H 2.1 0.1 
l/K,, is given in units of 10” M-l 
S.D., standard deviation. 
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Fig. 7. Inhibition data for 2C presented as a Dixon plot. [I], 
inhibitor concentration. 
lo6 M-l) (undiluted), 12.6 (10x diluted) and 10.4 (100x 
diluted). These data compare well to a statistical analysis 
that suggests that the discovery (at the 95 % confidence 
level) of an inhibitor only one log unit more potent 
than the lead compound, tacrine, would only have been 
possible within a pool size of 25 members. 
Discussion 
The average potency of all of the compounds in these 
pools is fairly high, as evidenced by the statistics showing 
that the lo-fold more potent nitrotacrine could be found 
in only a relatively small pool size. Lower average 
potency would cause the potent molecules to stand out 
more clearly, and so be detectable in larger pool sizes. In 
such situations, combinatorial methods are more useful 
to elucidate structure-activity relationships than to select 
one potent compound from a multitude of drug candi- 
dates. That is, the results of the pool screenings them- 
selves provide useful information about potency 
enhancement. These data also provide insight into the 
limits of pool screening for developing lead compounds 
in situations where the activity is relatively unresponsive 
to a major structural variation (e.g., changes in the sub- 
stituents at the 4-position of the cyclohexane ring) 
within the library. In general, the screening of large pools 
will be most effective when there is a significant distinc- 
tion among the activities of the constituents, which can 
be best achieved by incorporating the greatest molecular 
diversity into the building block sets. 
Because the structure of the complex between acetyl- 
cholinesterase and tacrine has been reported [14], it can 
be used to aid interpretation of the results of this study. 
Figure 8 shows the active site region of the X-ray 
crystal structure, modified by the inclusion of the nitro 
group at the appropriate position on the tetrahydro- 
acridine ring. The molecular interactions believed to be 
responsible for the high affinity of tacrine for acetyl- 
cholinesterase include a hydrogen bond between the 
ring nitrogen and the main-chain carbonyl of His440 
and between the amino nitrogen and a structural water 
molecule. A stacking interaction has been postulated 
between Phe330 (not shown) and the aromatic part of 
tacrine, as well as between tacrine and Trp84, making 
the drug the middle of a ‘sandwich’ formed by these 
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Fig. 8. Postulated structure of the 
complex between acetylcholinesterase 
and nitrotetrahydroacridine (2C). This 
structure is based on that reported in the 
crystal structure of Hare1 et a/. U41, 
modified only by the addition of an NO, 
group (highlighted in yellow) on the 
tetrahydroacridine ring. Atom colors: 
carbon, black; hydrogen, white; nitro- 
gen, blue; oxygen, red. 
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two residues. An important role in the interaction of 
the aromatic ring of tacrine with the enzyme may 
therefore be T-stacking and/or charge-transfer interac- 
tions, which would very likely be enhanced in a 
complex with the nitroaryl compound 2C. 
Significance 
This study exemplifies several of the key prin- 
ciples necessary for application of modern com- 
binatorial chemistry to the discovery or 
development of novel drug candidates. First, it 
uses an eficient chemical reaction, which was 
optimized on a selection of single compounds 
before the pool synthesis was conducted, that 
greatly increases molecular complexity through 
C-C bond formation. Second, it uses a direct 
method for deconvolution of the results of pool 
screening, and a statistical model to validate the 
results. Finally, it integrates structural informa- 
tion with the library screening results to generate 
a model of the key molecular interactions and 
potentially inform further rounds of synthesis 
and screening. 
A major challenge for combinatorial chemistry 
systems is to provide a straightforward way to 
identify the active compound(s). After all, the 
preparation of a large conglomeration of mole- 
cules has never been difficult for chemists; the 
challenge, which has been very effectively met 
during many decades of natural products chem- 
istry, has been determination of the structure of 
the active few among the many. Several strategies 
have been used to identify active compounds in 
combinatorial libraries. Microsequencing can be 
applied to those natural biopolymers for which 
methods already exist. Solid-phase chemistry, 
linking the molecule to a microscopic bead or 
surface location, permits molecular identification 
by tagging. Chemical, biochemical, or positional 
codes or tags can be used to identify active com- 
pounds in these libraries, but often limit the range 
of chemistry and diversity of assays that can be 
used. To conduct solution-phase assays, yet still 
gain the higher throughput associated with parallel 
synthesis of the library, assays must be performed 
on pools. Deconvolution (synthesis and testing to 
find active pools, re-synthesis of active sub-pools) 
is one way to discover active compounds in this 
type of pool screening, but it can be laborious. 
The indexing method offers the advantages of 
solution-phase assays without the iteration step. 
Materials and methods 
Pool condensation of cyclohexanones 
and o-cyanoanilines 
A solution of 6 mm01 of a cyclohexanone and 1 mm01 each of 
six 2-cyanoanilines in 2 ml of acetic acid was heated in an Ace 
pressure tube at 125 ‘C for 24-48 h.The solvent was removed 
under reduced pressure.The protocol was similar for the other 
dimension except the mixed reagent was 1 mm01 each of 12 
cyclohexanones and the unitary reagent was 12 mmol of a 
2-cyanoaniline. HPLC of the resulting tetra-hydroacridines was 
performed at 35 “C using a Nucleosil C-18 reverse phase 
column (150 x 4.6 mm) with a 4:l ratio of a 0.02 M 
NaH2P0, (pH 3) to acetonitrile as eluent, a flow rate of 
0.9-1.7 ml min-l, and 240 nm detection. 
Characterization of 1,2,3,4-tetrahydro-7-nitro- 
%aminoacridine 
Melting point (mp) (MeOH) 197-198 “C. Infrared 
absorbance (IR) (film): 3326, 3228, 1643, 1502 cm-l. ‘H 
NMR (CDCl,): 6 8.38 (d,J=3 Hz, lH), 8.22 (dd,]=3,9 Hz, 
lH), 6.80 (d,]=9 Hz, lH), 5.13 (br s, 2H, exchangeable), 
2.60-1.10 (m, 8H). Fast-atom bombardment mass spec- 
troscopy (FAEI MS) (m/z+H): 244. Analysis: calculated for 
C13H13N302: C, 64.19; H, 5.39; N, 17.27. Found: C, 64.10; 
H, 5.43; N, 17.14. 
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Characterization of 1,2,3,4-tetrahydro-7-nitro- 
2-(trimethylsilyl)-9-aminoacridine 
Mp (MeOH) 199-200 “C. IR (film): 3327,3224, 1648, 1496 
cm-l. lH NMR (CDCl,): 6 8.38 (d,j=3 Hz, lH), 8.22 (dd, 
_J=3,9 Hz, lH), 6.80 (d,]=9 Hz, IH), 5.13 (br s, 2H, exchange- 
able), 2.61-1.00 (m, 7H), 0.13 (s, 3H), 0.01 (s, 6H). FABMS 
(m/z+H): 316.AnaIysis: calc’d for C,,H,lN,O,Si: C, 60.93; H, 
6.71; N, 13.32. Found: C, 60.98; H, 6.66; N, 13.40. 
Characterization of 1,2,3,4-tetrahydro-?-nitro- 
2-(cyclohexyl)-9-aminoacridine 
Mp (MeOH) 194-196 ‘C. IR (film): 3327,3224,1646,1504 
cm-l. lH NMR (CDCl,): 6 8.57 (d,J=3 Hz, lH), 8.22 (dd, 
J=3,9 Hz, lH), 6.79 (d,J=9 Hz, lH), 5.12 (br s, 2H, exchange- 
able), 2.65-0.90 (m, 18H). FAE-MS (m/z+H): 326. Analysis: 
calc’d for C,,H,,N,O,: C, 70.13; H, 7.12; N, 12.99. Found: C, 
70.08; H, 7.22; N, 12.88. 
Characterization of 1,2,3,4-tetrahydro-7-nitro- 
2-(phenethyl)-9-amino-2-aza-acridine 
Isolated as a yellow oil. IR (film): 3332,3319, 1649, 1499 cm-l. 
IH NMR (CDCl,): 6 8.60-6.95 (m, 8H), 5.11 (br s, 2H, 
exchangeable), 2.85-2.65 (m, 6H), 2.47-2.12 (m, 4H). FAB- 
MS (m/z+H): 349,Analysis: calc’d for CZOH,,N,O,: C, 68.95; 
H, 5.79; N, 16.08. Found: C, 68.80; H, 5.88; N, 16.22. 
Characterization of 1,2,3,4-tetrahydro- 
6,7-dimethoxy-9-aminoacridine 
Isolated as a yellow gum. IR (film): 3320, 3305, 1652, 1500 
cm-l. lH NMR (CDCl,): 6 7.85 (s, lH), 7.64 (s, lH), 6.15 (br 
s, 2H, exchangeable), 3.85 (s, 3H), 3.79 (s, 3H), 2.02-1.02 (m, 
8H). FAI-MS (m/z+H): 259,Analysis: calc’d for C,,H,,N,O,: 
C. 69.74; H, 7.02; N, 10.84. Found: C, 69.70; H, 7.11; N, 10.96. 
Preparation of stock solutions from reaction pools 
An appropriate amount of a sub-library was weighed out and 
dissolved in methanol to prepare a 1 mM or 2 mM stock 
solution. The calculation of concentration was based upon 
the aggregate molecular weight of the sub-library. The stock 
solution was diluted with de-ionized water as required for 
inhibition studies. 
Inhibition of acetylcholinesterase 
A stock solution of electric eel acetylcholinesterase (Sigma, 
AChE) was prepared in deionized distilled water containing 1 
mg ml-l ammonium sulfate and stored at -20 “C. A 75 mM 
substrate solution of acetylthiocholine iodide was prepared in a 
potassium phosphate buffer, pH 8.0. A 0.01 M dithionitro- 
benzene (DTNB) solution was prepared in 0.1 M potassium 
phosphate buffer, pH 7.0 containing sodium bicarbonate. The 
AChE stock was thawed on ice before use, 5 ~1 of which was 
withdrawn and mixed with 995 I.rJ of deionized distilled water 
to make a 1:200 AChE solution. The enzymatic reaction was 
initiated at 25 ‘C by addition of 10 ~1 of I:200 AChE solution 
into an assay buffer of 0.1 M potassium phosphate, pH 8.0 
containing 20 I.L~ of 75 mM acetylthiocholine iodide (500 p,M), 
100 p,l of 0.01 M DTNB (333 PM), and serial dilutions of 
inhibitors (a tetrahydroacridine mixture).The reaction was fol- 
lowed at 25 “C by W-Vis at 412 nm for 3 min.The rate (AA 
per min) at 25 ‘C under the specified conditions was deter- 
mined by the increasing absorbance, which derives from the 
thionitrobenzene product released (E = 11 400) from DTNB 
by reaction with thiocholine. The IC,, value was obtained 
from Dixon plots, is defined as the inhibitor concentration 
required to inhibit control enzyme activity by 50 %, and is 
expressed as a concentration based on the stock solution con- 
centration of the sub-library. The concentration for each pool 
in the assay was calculated using the combined molecular 
weights of the expected pool members. 
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